Webinar: The Revision ACL - Technical Considerations to Improve Patient Outcomes
Online
Thursday, September 19, 2024
7:15 PM - 8:15 PM
iCalendar
UTC
This webinar is an AAOS member benefit!
AAOS members attend for free.
Can't make the live event? Don't worry! You can still register to receive a notification when the recording is available. You will have access for 2 years!
Description: The revision ACL requires a complex surgical algorithm. In the revision setting, we need to consider what surgery was done previously, along with the potential reasons as to why the ACL may have "failed", including concomitant injuries and underlying soft tissue or bony anatomy problems that may affect a successful outcome.
Please join us for a thoughtful discussion on ACL re-injury and surgical concepts to consider in the revision setting. This webinar will focus on opinions and technical considerations from four of the leading experts in the field.
Learning Objectives:
1. Understand the technical challenges related to the previous ACL surgery and how this affects a revision ACL. How to evaluate bone loss from previous ACL surgery and when to consider one vs two stage revision.
2. Identify when to consider a lateral extra-articular procedure into a revision ACL.
3. Understand when an osteotomy is indicated in a revision ACL. How much malalignment is too much?
4. Understand the effects of concomitant injuries on ACL retears. What is the role of the meniscus, MCL and posterolateral corner?
Director: Stephen Aoki, MD, FAAOS
Faculty: Mark Getelman, MD, FAAOS, Armando Vidal MD, FAAOS, James Voos, MD, FAAOS, Justin Ernat, MD, FAAOS
The American Academy of Orthopaedic Surgeons is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. The American Academy of Orthopaedic Surgeons designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.